Familial idiopathic pulmonary fibrosis. Evidence of lung inflammation in unaffected family members.

We evaluated 17 clinically unaffected members of three families with an autosomal dominant form of idiopathic pulmonary fibrosis for evidence of alveolar inflammation. Each person in the study was examined by gallium-67 scanning for a general estimate of pulmonary inflammation, and by bronchoalveolar lavage for characterization of the types of recovered cells and their state of activation. Eight of the 17 subjects had evidence of alveolar inflammation on the lavage studies. Supporting data included increased numbers of neutrophils and activated macrophages that released one or more neutrophil chemoattractants, and growth factors for lung fibroblasts--findings similar to those observed in patients with overt idiopathic pulmonary fibrosis. Four of these eight also had a positive gallium scan; in all the other clinically unaffected subjects the scan was normal. During a follow-up of two to four years in seven of the eight subjects who had evidence of inflammation, no clinical evidence of pulmonary fibrosis has appeared. These results indicate that alveolar inflammation occurs in approximately half the clinically unaffected family members at risk of inheriting autosomal dominant idiopathic pulmonary fibrosis. Whether these persons with evidence of pulmonary inflammation but no fibrosis will proceed to have clinically evident pulmonary fibrosis is not yet known.

[1]  M. Kamboh,et al.  Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes (Gm). , 1986, Chest.

[2]  R. Crystal,et al.  Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). , 1984, The New England journal of medicine.

[3]  R. Crystal,et al.  Role of fibronectin as a growth factor for fibroblasts , 1983, The Journal of cell biology.

[4]  A. Young,et al.  A polymorphic DNA marker genetically linked to Huntington's disease , 1983, Nature.

[5]  R. Crystal,et al.  Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders. , 1983, The Journal of clinical investigation.

[6]  N. Pawlowski,et al.  Human alveolar macrophages produce leukotriene B4. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Crystal,et al.  Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. , 1982, The Journal of clinical investigation.

[8]  R. Crystal,et al.  Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Crystal,et al.  Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. , 1981, The Journal of clinical investigation.

[10]  V. Ferrans,et al.  Interstitial lung disease: current concepts of pathogenesis, staging and therapy. , 1981, The American journal of medicine.

[11]  G. Balian,et al.  Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment , 1981, The Journal of experimental medicine.

[12]  H. Kleinman,et al.  Role of attachment factors and attractants in fibroblast chemotaxis. , 1980, The Journal of laboratory and clinical medicine.

[13]  R. Crystal,et al.  Is there a fibrotic gene? , 1980, Chest.

[14]  J. Foidart,et al.  Enzyme-linked immunoassay (ELISA) for connective tissue components. , 1980, Analytical biochemistry.

[15]  B. Burrows,et al.  Cryptogenic fibrosing alveolitis: clinical features and their influence on survival , 1980, Thorax.

[16]  V. Ferrans,et al.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. , 1979, The American journal of pathology.

[17]  J D Fulmer,et al.  Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis. , 1979, The Journal of clinical investigation.

[18]  R. Crystal,et al.  Bronchoalveolar Lavage in Interstitial Lung Disease , 1978 .

[19]  W. Roberts,et al.  Small airways in idiopathic pulmonary fibrosis. Comparison of morphologic and physiologic observations. , 1977, The Journal of clinical investigation.

[20]  W. Roberts,et al.  Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. , 1977, The Journal of clinical investigation.

[21]  W. Roberts,et al.  Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. , 1976, Annals of internal medicine.

[22]  L. Mccormack,et al.  Familial Hamman-Rich syndrome. Report of eight cases. , 1969, Diseases of the chest.

[23]  A. Adelman,et al.  Familial fibrocystic pulmonary dysplasia: a detailed family study. , 1966, Canadian Medical Association journal.

[24]  J. Frymoyer,et al.  A FAMILY STUDY OF IDIOPATHIC PULMONARY FIBROSIS. A POSSIBLE DYSPROTEINEMIC AND GENETICALLY DETERMINED DISEASE. , 1965, The American journal of medicine.

[25]  B. Koch FAMILIAL FIBROCYSTIC PULMONARY DYSPLASIA: OBSERVATIONS IN ONE FAMILY. , 1965, Canadian Medical Association journal.

[26]  W. L. Donohue,et al.  Familial fibrocystic pulmonary dysplasia and its relation to Hamman-Rich syndrome. , 1959, Pediatrics.

[27]  J. Macmillan Familial pulmonary fibrosis. , 1951, Diseases of the chest.